Prevalence of metabolic syndrome in pre- and postmenopausal women

The objective of this study was to determine the prevalence of metabolic syndrome (MS) and its components among pre- and postmenopausal women, as well as the association between menopausal status and MS. A retrospective study was conducted at a reference cardiology outpatient clinic in a city locate...

Full description

Saved in:
Bibliographic Details
Published in:Archives of Endocrinology and Metabolism Vol. 61; no. 2; pp. 160 - 166
Main Authors: Marchi, Ricardo de, Dell'Agnolo, Cátia Millene, Lopes, Tiara Cristina Romeiro, Gravena, Angela Andréia França, Demitto, Marcela de Oliveira, Brischiliari, Sheila Cristina Rocha, Borghesan, Deise Helena Pelloso, Carvalho, Maria Dalva de Barros, Pelloso, Sandra Marisa
Format: Journal Article
Language:English
Published: Brazil Sociedade Brasileira de Endocrinologia e Metabologia 01-03-2017
Brazilian Society of Endocrinology and Metabolism
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of this study was to determine the prevalence of metabolic syndrome (MS) and its components among pre- and postmenopausal women, as well as the association between menopausal status and MS. A retrospective study was conducted at a reference cardiology outpatient clinic in a city located in Northwestern Paraná State, Brazil. A total of 958 medical records of symptomatic climacteric women evaluated between 2010 and 2014 were analyzed. The study consisted of two groups: pre- and post-menopausal women. MS was characterized according to the criteria of the National Cholesterol Education Program's Adult Treatment Panel III - NCEP-ATP III-2005. MS was observed in 18.5% of the total study population; 9.4% of the premenopausal women and 22.2% of the postmenopausal women displayed MS, corresponding to a relative risk of 2.75. In addition, the frequency of MS increased with age. Regarding the components of MS, postmenopausal women were more likely to have high density lipoprotein (HDL-C) levels < 50 mg/dL; systolic blood pressure (SBP) values ≥ 130 mmHg or diastolic blood pressure (DBP) values ≥ 85 mmHg; and fasting glucose levels ≥ 100 mg/dL. MS was more prevalent among postmenopausal women than among premenopausal women.
Bibliography:Disclosure: no potential conflict of interest relevant to this article was reported.
ISSN:2359-3997
2359-4292
2359-4292
2359-3997
DOI:10.1590/2359-3997000000253